ArticleBMC plant biology2025
Functional characterization of PavIAA6 in sweet cherry: a key regulator of pigmentation, flavor, and nutrient accumulation.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe ripening of sweet cherries involves synchronized improvements in color, taste, and nutritional content. Therefore, it is crucial to study changes at the genetic level during the ripening of sweet cherries.
resultsDetermining the essential genes involved in ripening is vital for fruit quality management. In this study, transcriptomic analysis of various ripening stages identified PavIAA6, a key Aux/IAA gene family member, as having an expression pattern closely associated with fruit color flavor, and nutrient changes. Functional investigations, including overexpression (PavIAA6-OE) and virus-induced gene silencing (PavIAA6-VIGS), demonstrated that PavIAA6 drives the ripening process by integrating hormone signaling and metabolic pathways. PavIAA6 is vital for modulating the expression of essential genes related to auxin and abscisic acid metabolism, including PavYUCC, PavNCED, and PavZEP, which are involved in indole-3-acetic acid and abscisic acid biosynthesis. Moreover, PavIAA6 activates flavonoid biosynthesis genes PavANS, PavUFGT, and PavDFR, as well as ascorbic acid biosynthesis genes PavGPP and PavGDH, thereby promoting anthocyanin and antioxidant accumulation. PavIAA6 modulates the composition of soluble sugars by upregulating the sucrose metabolism-related genes PavINV and PavSUS2.
conclusionsIn conclusion, our findings reveal that PavIAA6 is a key ripening-promoting factor and suggest its potential as a novel molecular target for the breeding of improved sweet cherry varieties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.